Humana (HUM) Tops Q2 EPS by 41c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Humana Reports Second Quarter 2017 Financial Results; Raises Full Year 2017 Guidance; Provides Update on Bonus Year 2018 Star Ratings
August 2, 2017 6:30 AM EDT2Q17 earnings per diluted common share (EPS) of $4.46 on a GAAP basis, $3.49 Adjusted EPS Full year 2017 guidance raised to approximately $17.83 EPS on a GAAP basis, approximately $11.50 Adjusted EPS Individual Medicare Advantage results significantly outperforming managements original expectations Approximately 74 percent of the companys Medicare Advantage members are now expected to be in 4-Star plans or higher for bonus year 2018
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) today reported diluted... More
